Biological laboratory with AI management to launch in Zhangjiang
Zhu Pengcheng, founder and CEO of ATLATL Innovation Cluster, delivers a keynote speech at a seminar on how to make Shanghai a global biotechnology center on May 7. [Photo/whb.cn]
A new concept biomedical laboratory, AVIC + Lab, was described by Zhu Pengcheng, founder and CEO of ATLATL Innovation Cluster (a shared laboratory space for high-potential life sciences in Shanghai's Zhangjiang Science City), at a seminar on May 7.
"AVIC + Lab" represents artificial intelligence (AI), venture capital (VC), intellectual property (IP), contract research organization (CRO) and laboratory facilities.
According to Zhu, AVIC+Lab could be a feasible way to accelerate the R&D of self-developed biological medicine in Shanghai.
Zhu worked in Boston for a long time. After comparing the differences between Shanghai and Boston in biomedical R&D, he believes that although Boston has more advantages in core technology and cutting-edge R&D, Shanghai has certain advantages in industrial amplification and CRO.
The key to give full play to Shanghai’s advantages is to build a comprehensive platform integrating these elements.
"With such a platform, projects that used to need more than 10 million yuan ($1.46 million) of investment can be launched with only tens of thousands of yuan. This will greatly lower the threshold for innovators to participate in biomedical R&D," said Zhu.
Currently, Zhu is working on the world's first biological laboratory based on AI management in Zhangjiang.
35 measures to promote talent development in PudongPudong in Shanghai released 35 measures on April 3 to promote the development of talented personnel.